SCHEMBL7125849

SCHEMBL7125849

CCOP(=O)(CN(CCc1ccccn1)c1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)OCC

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
GAA P10253 1/20 0.44
RAF1 P04049 2/20 0.40
MAP2K1 Q02750 2/20 0.40
KDM4E B2RXH2 6/20 0.39
ALDH1A1 P00352 5/20 0.39
HMGCR P04035 2/20 0.38
NR1I2 O75469 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TDP1 Q9NUW8 3/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
RECQL P46063 1/20 0.37
HIF1A Q16665 1/20 0.37
POLB P06746 1/20 0.37
TSHR P16473 1/20 0.37
ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7117955 0.90 GAA (0.43) MEN1KMT2AGAARAF1MAP2K1
SCHEMBL8767353 0.86 MEN1 (0.49) MEN1KMT2AGAARAF1MAP2K1
SCHEMBL8766494 0.85 HMGCR (0.44) MEN1KMT2AGAAALDH1A1HMGCR
SCHEMBL7119208 0.82 HMGCR (0.43) MEN1KMT2AGAARAF1MAP2K1
SCHEMBL8766155 0.81 HMGCR (0.42) MEN1KMT2AGAARAF1MAP2K1
SCHEMBL7125857 0.81 HMGCR (0.41) MEN1KMT2AGAAHMGCRNR1I2
SCHEMBL8766578 0.81 HMGCR (0.44) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL8766162 0.79 HMGCR (0.42) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL7123134 0.77 HMGCR (0.44) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL7122163 0.76 NR1H4 (0.42) MEN1KMT2AGAAALDH1A1HMGCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0835116-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SYMPHAR S.A. (CH) 1998-04-15 EP claimed
EP-0559079-B1 Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them SYMPHAR SA (CH) 1997-08-13 EP claimed
WO-1997002037-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SYMPHAR S.A. (CH) 1997-01-23 WO claimed
US-5424303-A For treating hypercholesterolemia and hyperlipidemia SYMPHAR SA (CH) 1995-06-13 US claimed
EP-0559079-A1 Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them SYMPHAR S.A. (CH) 1993-09-08 EP claimed
US-6660724-B1 Aminophosphonates alpha substituted by phenol; lipoprotein lowering activity ILEX PRODUCTS, INC. 2003-12-09 US disclosed
EP-0559079-B1 Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them SYMPHAR SA (CH) 1997-08-13 EP disclosed
US-5424303-A For treating hypercholesterolemia and hyperlipidemia SYMPHAR SA (CH) 1995-06-13 US disclosed
EP-0559079-A1 Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them SYMPHAR S.A. (CH) 1993-09-08 EP disclosed